Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM -1.13%76 Future 3-5Y EPS without NRI Growth Rate is 13.09 as of Sep. 02, 2026. GuruFocus rates BKK:RAM with a GF Score™ of 76/100 and a GF Value™ of ฿43.22 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 197 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks worse than 64.97% on this metric.
Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.
Ramkhamhaeng Hospital PCL Future 3-5Y EPS without NRI Growth Rate Related Terms
BKK:RAM vs HCA, THC, EHC: Future 3-5Y EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL Future 3-5Y EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's Future 3-5Y EPS without NRI Growth Rate falls into.
What does a Future 3-5Y EPS without NRI Growth Rate of 13.09 mean?
Ramkhamhaeng Hospital PCL (BKK:RAM) has a Future 3-5Y EPS without NRI Growth Rate of 13.09 as of Sep. 02, 2026. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Ramkhamhaeng Hospital PCL and its competitors. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #128 out of 197 companies in the Healthcare Providers & Services industry, placing it in the top 65%.
Is Ramkhamhaeng Hospital PCL's Future 3-5Y EPS without NRI Growth Rate too high?
Ramkhamhaeng Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate is 13.09. The Healthcare Providers & Services industry median Future 3-5Y EPS without NRI Growth Rate is 17.57. Ramkhamhaeng Hospital PCL's value of 13.09 is 25.5% below this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #128 out of 197 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's Future 3-5Y EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #128 out of 197 companies for Future 3-5Y EPS without NRI Growth Rate. This places Ramkhamhaeng Hospital PCL in the lower half of its industry. The industry median Future 3-5Y EPS without NRI Growth Rate is 17.57. Ramkhamhaeng Hospital PCL's value of 13.09 is 25.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median Future 3-5Y EPS without NRI Growth Rate among Healthcare Providers & Services companies is 17.57, based on 197 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate of 13.09 is 25.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y EPS without NRI Growth Rate mean?
A high Future 3-5Y EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period. View historical data for Ramkhamhaeng Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Future 3-5Y EPS without NRI Growth Rate is 17.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current Future 3-5Y EPS without NRI Growth Rate is 13.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL (BKK:RAM) is currently considered Possible Value Trap. The stock's GF Value™ is ฿43.22, compared to a current price of ฿17.50 — trading 59.5% below its estimated fair value. The current Future 3-5Y EPS without NRI Growth Rate is 13.09 and 25.5% below the Healthcare Providers & Services industry median of 17.57. Ramkhamhaeng Hospital PCL's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y EPS without NRI Growth Rate calculated?
Future 3-5Y EPS without NRI Growth Rate is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM), the current Future 3-5Y EPS without NRI Growth Rate is 13.09 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.50 is trading 59.5% below its estimated GF Value™ of ฿43.22.
GuruFocus considers Ramkhamhaeng Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:RAM:
Future 3-5Y EPS without NRI Growth Rate: 13.09
GF Value™: ฿43.22 vs. price of ฿17.50 (59.5% below fair value)
Industry Position: 25.5% below the Healthcare Providers & Services median (#128 of 197)
No single metric tells the full story. See the BKK:RAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
76GF Score
Get the complete analysis for BKK:RAM
Future 3-5Y EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM has been successfully added to your 
